Diagnostic Hybrids is now a wholly owned subsidiary of Quidel.

 


Diagnostic HYBRIDS Presented Innovative Developments at 22nd Clinical Virology Symposium

May 10, 2006
Clearwater, Fl. May 10, 2006. Diagnostic HYBRIDS presented the latest innovations in cell culture on May 1st at the 22nd Clinical Virology Symposium. Topics ranged from Respiratory and Transport Innovations to Human Metapneumovirus from a Clinical perspective and Monoclonal Antibody Development. Diagnostic HYBRIDS’ presentation registered an attendance of over 150 interested customers.

In addition, 27 scientific posters were presented highlighting Diagnostic HYBRIDS’ new and current products including studies on monoclonal antibodies, human metapneumovirus, respiratory diseases, herpes family viruses, transport and media, and dual simultaneous screening of viruses.